Showing 10 of 30 recruiting trials for “upper-tract-urothelial-carcinoma”
Efficacy and Safety of Tislelizumab in Combination With Disitamab-vedotin as Neoadjuvant Therapy for HER2-positive High-risk Upper Tract Urothelial Carcinoma (UTUC)
👨⚕️ Hailong Hu, MD,PhD, Tianjin Medical University Second Hospital📍 1 site📅 Started Dec 2022View details ↗
A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma
RecruitingNCT05595408 ↗
Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma
RecruitingNCT06652009 ↗
Radical Radiotherapy Versus Radical Surgery for UTUC
RecruitingNCT06120374 ↗
Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC
👨⚕️ Xiaoying Li, M.D., Department of Radiotherapy Oncology, Peking University First Hospital📍 3 sites📅 Started Jan 2022View details ↗
RecruitingNCT06598761 ↗
Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC
Gemcitabine Versus Water Irrigation in Upper Tract Urothelial Carcinoma
RecruitingNCT05438537 ↗
A Comprehensive Prospective Assessment of the Physical and Biological Effects of Upper Tract Urothelial Cancer (UTUC)
👨⚕️ Jeremy Yuen-Chun TEOH, FRCS(Ed) MBBS, Chinese University of Hong Kong📍 1 site📅 Started Nov 2021View details ↗
Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract
RecruitingNCT06116396 ↗
Liquid Biospy for Urinary Cancers
← PreviousPage 2 of 2
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →